Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander C Wiseman

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Clinical Transplantation|September 8, 2009
Standard criteria donor pancreas donation status is associated with improved kidney transplant outcomesAndrew S Weiss, Gerard Smits, Alexander C Wiseman
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 29, 2013
The impact of pre-transplant dialysis on simultaneous pancreas-kidney versus living donor kidney transplant outcomesAlexander C Wiseman, Edmund Huang, Mandana Kamgar, et al.
Clinical Transplantation|August 12, 2009
Corticosteroid elimination in simultaneous liver-kidney transplantation recipientsNicholas K Weber, Alexander C Wiseman, James F Trotter
Clinical Transplants|July 5, 2012
Clinical significance of post kidney transplant de novo DSA in otherwise stable graftsJames E Cooper, Jane Gralla, Laurence Chan, et al.
Transplantation|August 5, 2010
Preemptive retransplant for BK virus nephropathy without concurrent transplant nephrectomyJames E Cooper, Janna Huskey, Laurence Chan, et al.
Transplantation|July 26, 2005
Page kidney causing reversible acute renal failure: an unusual complication of transplant biopsyEric M Gibney, Charles L Edelstein, Alexander C Wiseman, et al.
Clinical Transplantation|January 31, 2014
The risk of acute rejection and the influence of induction agents in lower-risk African American kidney transplant recipients receiving modern immunosuppressionJane Gralla, Charles N Le, James E Cooper, et al.
Transplantation|June 18, 2014
High dose intravenous immunoglobulin therapy for donor-specific antibodies in kidney transplant recipients with acute and chronic graft dysfunctionJames E Cooper, Jane Gralla, Patrick Klem, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 25, 2008
Aggressive immunosuppression minimization reduces graft loss following diagnosis of BK virus-associated nephropathy: a comparison of two reduction strategiesAndrew S Weiss, Jane Gralla, Larry Chan, et al.
Clinical Transplants|August 7, 2014
Donor specific antibodies before and after kidney transplant: the University of Colorado ExperienceJames E Cooper, Jane Gralla, Oluwafisayo Adebiyi, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Clinical Transplantation|September 8, 2009
Standard criteria donor pancreas donation status is associated with improved kidney transplant outcomesAndrew S Weiss, Gerard Smits, Alexander C Wiseman
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 29, 2013
The impact of pre-transplant dialysis on simultaneous pancreas-kidney versus living donor kidney transplant outcomesAlexander C Wiseman, Edmund Huang, Mandana Kamgar, et al.
Clinical Transplantation|August 12, 2009
Corticosteroid elimination in simultaneous liver-kidney transplantation recipientsNicholas K Weber, Alexander C Wiseman, James F Trotter
Clinical Transplants|July 5, 2012
Clinical significance of post kidney transplant de novo DSA in otherwise stable graftsJames E Cooper, Jane Gralla, Laurence Chan, et al.
Transplantation|August 5, 2010
Preemptive retransplant for BK virus nephropathy without concurrent transplant nephrectomyJames E Cooper, Janna Huskey, Laurence Chan, et al.
Transplantation|July 26, 2005
Page kidney causing reversible acute renal failure: an unusual complication of transplant biopsyEric M Gibney, Charles L Edelstein, Alexander C Wiseman, et al.
Clinical Transplantation|January 31, 2014
The risk of acute rejection and the influence of induction agents in lower-risk African American kidney transplant recipients receiving modern immunosuppressionJane Gralla, Charles N Le, James E Cooper, et al.
Transplantation|June 18, 2014
High dose intravenous immunoglobulin therapy for donor-specific antibodies in kidney transplant recipients with acute and chronic graft dysfunctionJames E Cooper, Jane Gralla, Patrick Klem, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 25, 2008
Aggressive immunosuppression minimization reduces graft loss following diagnosis of BK virus-associated nephropathy: a comparison of two reduction strategiesAndrew S Weiss, Jane Gralla, Larry Chan, et al.
Clinical Transplants|August 7, 2014
Donor specific antibodies before and after kidney transplant: the University of Colorado ExperienceJames E Cooper, Jane Gralla, Oluwafisayo Adebiyi, et al.
Pageof 6